LATAM LOWERS LDL-C
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 520 participants.
Also called NCT06501443
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 520 participants
- Sponsor
- Registry
-
NCT06501443
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Argentina, Brazil
- Registry status
- Recruiting
Technical summary
Registry record NCT06501443. Randomized; no masking; primary purpose treatment. Start 2025-02-11 (actual); primary completion 2026-11-27 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- LATAM LOWERS LDL-C
- Condition
- Hypercholesterolaemia
- Intervention (Drug)
- Usual care
- Intervention (Drug)
- KJX839
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct06501443- Content hash
2a413503db79cd7e63ac361457aae933f78c40c8a0508fa7584c3b3b1d2232dd